Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-11

FDA Approved: VISUDYNE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for VISUDYNE (verteporfin for injection) from Bausch & Lomb Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Visudyne (verteporfin)

Snippet

SUPPL AP for VISUDYNE (VERTEPORFIN FOR INJECTION)